AZD7325 is a high affinity, selective modulator of the GABAA receptor system.
Research Site, Philadelphia, Pennsylvania, United States
Research Site, Stockholm, Sweden
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.